SIBEL BLAU

Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology PUYALLUP, WA NPI 1962490797

General Payments — all program years on this page

$21,022.62

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 94
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $3,729.82 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $3,150.002
Food and Beverage $559.8218
Education $20.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $5,289.6720
2019 $1,217.0616
2020 $13.291
2021 $8,349.095
2022 $655.8111
2023 $1,767.8820
2024 $3,729.8221

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078861595 Janssen Scientific Affairs, LLC $2,100.00 06/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078861597 Janssen Scientific Affairs, LLC $1,050.00 11/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1078861601 Janssen Scientific Affairs, LLC $50.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086778695 Novartis Pharmaceuticals Corporation $24.64 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101123912 Celgene Corporation $19.88 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101381536 E.R. Squibb & Sons, L.L.C. $20.65 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103336166 ABBVIE INC. $15.51 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103336168 ABBVIE INC. $16.76 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110531771 AstraZeneca Pharmaceuticals LP $19.77 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110537094 AstraZeneca Pharmaceuticals LP $14.97 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110538259 AstraZeneca Pharmaceuticals LP $135.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1110781566 Eisai Inc. $25.15 07/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116130889 GlaxoSmithKline, LLC. $21.99 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116448352 GlaxoSmithKline, LLC. $24.26 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116602069 GlaxoSmithKline, LLC. $30.20 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120852777 BeiGene USA, Inc. $78.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126832164 Genmab U.S., Inc. $21.57 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131179338 PFIZER INC. $21.31 01/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131911433 PFIZER INC. $0.95 01/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133806897 Gilead Sciences, Inc. $19.21 12/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143486671 Aveo Pharmaceuticals, Inc. $20.00 11/19/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.